According to Clew Medical, an AI forecasting and analyzing platform, it has gained authorization from the Food and Drug Administration (FDA) in screening tools of COVID-19. - Clew Medical is specialized in analyzing medical information and forecasts a life-threatening phenomenon, and it will provide support with clients’ care decisions. Moreover, it could help to recognize high-risk patients in COVID-19. - AI algorithms could recognize respiratory failures several hours in advance, which could allow doctors to do extra assessments. This could also help to do an early intervention and resource management.